27/05/2026
How can the global health community move from cervical cancer elimination to the elimination of all HPV-related disease?
Last week, on the sidelines of the World Health Assembly, NOMAN is an Island: Race to End HPV and Global Action on Men’s Health convened an invitation-only breakfast dialogue in Geneva: “From Cervical Cancer Elimination to HPV Elimination: Shaping the global strategy for HPV vaccination beyond 2030”.
The roundtable brought together senior public health leaders, policymakers, researchers, practitioners and advocates to examine how routine universal HPV vaccination can be embedded as a core pillar of the next global prevention strategy.
Discussion focused on recent global and regional policy developments, the latest scientific and strategic advances in HPV prevention, and the equity-based case for vaccinating both boys and girls. Participants also explored how emerging evidence, social research and policy momentum can support a shift beyond a cervical cancer-only approach towards the elimination of all HPV-related disease.
A sincere thank you to our speakers and contributors:
- Dr André Ilbawi, World Health Organization
- Professor Anna Giuliano, Moffitt Cancer Center
- Laure de Montandon, Association No Taboo
- Dr Susan Kelly, London School of Hygiene and Tropical Medicine and Mwanza Intervention Trials Unit
- Professor Matti Lehtinen, Karolinska Institutet
- Prof Bettina Borisch Borisch, World Federation of Public Health Associations - WFPHA
Thank you also to Peter Baker, Chief Executive of Global Action on Men’s Health, for co-chairing the discussion alongside David Winterflood, Director of NOMAN, and to Dr. Tim Shand. Tristan Almada, NOMAN President also attended and shared reflections.
This dialogue forms part of our joint advocacy work with Global Action on Men’s Health to advance routine universal HPV vaccination and help shape a post-2030 strategy that protects everyone from HPV-related diseases.